Skip to content
PubMed This is a summary of 45 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 45 referenced papers

Top Authors

Matthias R. Baumgartner
University of Zurich
Viktor Kožich
Charles University
Martina Huemer
University Children's Hospital Zurich
D. Sean Froese
University of Zurich
Manuel Schiff
Hôpital Necker-Enfants Malades
Carlo Dionisi‐Vici
Bambino Gesù Children's Hospital
A. A. M. Morris
University of Manchester
Stefan Kölker
Heidelberg University
Florian Gleich
Heidelberg University
Henk J. Blom
Erasmus MC

Top Institutions

Ranked by publications Top 10 institutions
05

University of Manchester

Manchester, United Kingdom

11 papers
09

Centre for Biomedical Network Research on Rare Diseases

Madrid, Spain

10 papers
10

Erasmus MC

Rotterdam, The Netherlands

15 papers

References

References (45)
  1. 1

    Insights into severe 5,10-methylenetetrahydrofolate reductase deficiency: molecular genetic and enzymatic characterization of 76 patients.

    Burda P, Schäfer A, Suormala T, et al.

    Human mutation 2015; (36(6)):611-21 doi:10.1002/humu.22779.

    PMID: 25736335
  2. 2

    Newborn screening for homocystinurias and methylation disorders: systematic review and proposed guidelines.

    Huemer M, Kožich V, Rinaldo P, et al.

    Journal of inherited metabolic disease 2015; (38(6)):1007-19 doi:10.1007/s10545-015-9830-z.

    PMID: 25762406
  3. 3

    Clinical pattern, mutations and in vitro residual activity in 33 patients with severe 5, 10 methylenetetrahydrofolate reductase (MTHFR) deficiency.

    Huemer M, Mulder-Bleile R, Burda P, et al.

    Journal of inherited metabolic disease 2016; (39(1)):115-24 doi:10.1007/s10545-015-9860-6.

    PMID: 26025547
  4. 4

    Treatment with Mefolinate (5-Methyltetrahydrofolate), but Not Folic Acid or Folinic Acid, Leads to Measurable 5-Methyltetrahydrofolate in Cerebrospinal Fluid in Methylenetetrahydrofolate Reductase Deficiency.

    Knowles L, Morris AA, Walter JH

    JIMD reports 2016; (29()):103-107 doi:10.1007/8904_2016_529.

    PMID: 26898294
  5. 5

    Homocysteinemia due to MTHFR deficiency in a young adult presenting with bilateral lens subluxations.

    Couser NL, McClure J, Evans MW, et al.

    Ophthalmic genetics 2017; (38(1)):91-94 doi:10.3109/13816810.2016.1143017.

    PMID: 27046515
  6. 6

    MTHFR: Addressing Genetic Counseling Dilemmas Using Evidence-Based Literature.

    Levin BL, Varga E

    Journal of genetic counseling 2016; (25(5)):901-11 doi:10.1007/s10897-016-9956-7.

    PMID: 27130656
  7. 7

    Determination of CSF 5-methyltetrahydrofolate in children and its application for defects of folate transport and metabolism.

    Akiyama M, Akiyama T, Kanamaru K, et al.

    Clinica chimica acta; international journal of clinical chemistry 2016; (460()):120-5.

    PMID: 27363740
  8. 8

    Functional characterization of missense mutations in severe methylenetetrahydrofolate reductase deficiency using a human expression system.

    Burda P, Suormala T, Heuberger D, et al.

    Journal of inherited metabolic disease 2017; (40(2)):297-306 doi:10.1007/s10545-016-9987-0.

    PMID: 27743313
  9. 9

    Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency.

    Huemer M, Diodato D, Schwahn B, et al.

    Journal of inherited metabolic disease 2017; (40(1)):21-48 doi:10.1007/s10545-016-9991-4.

    PMID: 27905001
  10. 10

    Rapidly progressive psychotic symptoms triggered by infection in a patient with methylenetetrahydrofolate reductase deficiency: a case report.

    Iida S, Nakamura M, Asayama S, et al.

    BMC neurology 2017; (17(1)):47 doi:10.1186/s12883-017-0827-0.

    PMID: 28241805
  11. 11

    Methylene Tetrahydrofolate Reductase Deficiency: the Hidden Risk in Paediatric Anaesthesia.

    Orhon ZN, Koltka EN, Tüfekçi S, et al.

    Turkish journal of anaesthesiology and reanimation 2017; (45(5)):277-281 doi:10.5152/TJAR.2017.68366.

    PMID: 29114412
  12. 12

    Manifestations of neurological symptoms and thromboembolism in adults with MTHFR-deficiency.

    Rommer PS, Zschocke J, Fowler B, et al.

    Journal of the neurological sciences 2017; (383()):123-127 doi:10.1016/j.jns.2017.10.035.

    PMID: 29246599
  13. 13

    Severe 5,10-methylenetetrahydrofolate reductase deficiency: a rare, treatable cause of complicated hereditary spastic paraplegia.

    Perna A, Masciullo M, Modoni A, et al.

    European journal of neurology 2018; (25(3)):602-605 doi:10.1111/ene.13557.

    PMID: 29284203
  14. 14

    Adolescence/adult onset MTHFR deficiency may manifest as isolated and treatable distinct neuro-psychiatric syndromes.

    Gales A, Masingue M, Millecamps S, et al.

    Orphanet journal of rare diseases 2018; (13(1)):29 doi:10.1186/s13023-018-0767-9.

    PMID: 29391032
  15. 15

    Structural basis for the regulation of human 5,10-methylenetetrahydrofolate reductase by phosphorylation and S-adenosylmethionine inhibition.

    Froese DS, Kopec J, Rembeza E, et al.

    Nature communications 2018; (9(1)):2261 doi:10.1038/s41467-018-04735-2.

    PMID: 29891918
  16. 16

    High incidence of maternal vitamin B12 deficiency detected by newborn screening: first results from a study for the evaluation of 26 additional target disorders for the German newborn screening panel.

    Gramer G, Fang-Hoffmann J, Feyh P, et al.

    World journal of pediatrics : WJP 2018; (14(5)):470-481 doi:10.1007/s12519-018-0159-1.

    PMID: 29948967
  17. 17

    Newborn screening for homocystinurias: Recent recommendations versus current practice.

    Keller R, Chrastina P, Pavlíková M, et al.

    Journal of inherited metabolic disease 2019; (42(1)):128-139 doi:10.1002/jimd.12034.

    PMID: 30740731
  18. 18

    Phenotype, treatment practice and outcome in the cobalamin-dependent remethylation disorders and MTHFR deficiency: Data from the E-HOD registry.

    Huemer M, Diodato D, Martinelli D, et al.

    Journal of inherited metabolic disease 2019; (42(2)):333-352 doi:10.1002/jimd.12041.

    PMID: 30773687
  19. 19

    Betaine anhydrous in homocystinuria: results from the RoCH registry.

    Valayannopoulos V, Schiff M, Guffon N, et al.

    Orphanet journal of rare diseases 2019; (14(1)):66 doi:10.1186/s13023-019-1036-2.

    PMID: 30871635
  20. 20

    Venous thrombosis after nitrous oxide abuse, a case report.

    Pratt DN, Patterson KC, Quin K

    Journal of thrombosis and thrombolysis 2020; (49(3)):501-503 doi:10.1007/s11239-019-02010-9.

    PMID: 31820264
  21. 21

    Methylene Tetrahydrofolate Reductase Deficiency.

    Kaur R, Correa ARE, Thakur S, et al.

    Indian journal of pediatrics 2020; (87(11)):951-953 doi:10.1007/s12098-020-03290-3.

    PMID: 32451826
  22. 22

    Methylenetetrahydrofolate Reductase Deficiency: A Case Report.

    Hale N, Minzola D

    AANA journal 2020; (88(4)):303-306.

    PMID: 32718428
  23. 23

    Clinical and molecular characterization of adult patients with late-onset MTHFR deficiency.

    Marelli C, Lavigne C, Stepien KM, et al.

    Journal of inherited metabolic disease 2021; (44(3)):777-786 doi:10.1002/jimd.12323.

    PMID: 33089527
  24. 24

    Shifting landscapes of human MTHFR missense-variant effects.

    Weile J, Kishore N, Sun S, et al.

    American journal of human genetics 2021; (108(7)):1283-1300 doi:10.1016/j.ajhg.2021.05.009.

    PMID: 34214447
  25. 25

    A rise in cases of nitrous oxide abuse: neurological complications and biological findings.

    Einsiedler M, Voulleminot P, Demuth S, et al.

    Journal of neurology 2022; (269(2)):577-582 doi:10.1007/s00415-021-10702-7.

    PMID: 34245346
  26. 26

    Pilot Study on Neonatal Screening for Methylmalonic Acidemia Caused by Defects in the Adenosylcobalamin Synthesis Pathway and Homocystinuria Caused by Defects in Homocysteine Remethylation.

    Kagawa R, Tajima G, Maeda T, et al.

    International journal of neonatal screening 2021; (7(3)) doi:10.3390/ijns7030039.

    PMID: 34287232
  27. 27

    Variable neurological phenotypes of homocystinuria caused by biallelic methylenetetrahydrofolate reductase variants.

    Moirangthem A, Saxena D, Masih S, et al.

    Clinical dysmorphology 2022; (31(2)):59-65 doi:10.1097/MCD.0000000000000407.

    PMID: 34845156
  28. 28

    Hypoventilation and progressive encephalopathy in a neonate with MTHFR deficiency.

    Vemireddy K, Panigrahy N, Lingappa L, Chirla D

    BMJ case reports 2022; (15(1)) doi:10.1136/bcr-2021-246431.

    PMID: 34983810
  29. 29

    Postauthorization safety study of betaine anhydrous.

    Mütze U, Gleich F, Garbade SF, et al.

    Journal of inherited metabolic disease 2022; (45(4)):719-733 doi:10.1002/jimd.12499.

    PMID: 35358327
  30. 30

    Inherited metabolic diseases mimicking hereditary spastic paraplegia (HSP): a chance for treatment.

    Teive HAG, Camargo CHF, Pereira ER, et al.

    Neurogenetics 2022; (23(3)):167-177 doi:10.1007/s10048-022-00688-3.

    PMID: 35397036
  31. 31

    Influence of early identification and therapy on long-term outcomes in early-onset MTHFR deficiency.

    Yverneau M, Leroux S, Imbard A, et al.

    Journal of inherited metabolic disease 2022; (45(4)):848-861 doi:10.1002/jimd.12504.

    PMID: 35460084
  32. 32

    Hydrocephalus presented as the prominent symptom of severe 5,10-methylenetetrahydrofolate reductase deficiency in an infant: A case report.

    Ding Y, Wang Q, Gong CX

    Medicine international 2022; (2(2)):12 doi:10.3892/mi.2022.37.

    PMID: 36699103
  33. 33

    Nitrous oxide abuse leading to extreme homocysteine levels and thrombosis in young adults: a case series.

    Caris MG, Kuipers RS, Kiestra BE, et al.

    Journal of thrombosis and haemostasis : JTH 2023; (21(2)):276-283 doi:10.1016/j.jtha.2022.10.002.

    PMID: 36700505
  34. 34

    Contribution of Genetic Test to Early Diagnosis of Methylenetetrahydrofolate Reductase (MTHFR) Deficiency: The Experience of a Reference Center in Southern Italy.

    Barretta F, Uomo F, Fecarotta S, et al.

    Genes 2023; (14(5)) doi:10.3390/genes14050980.

    PMID: 37239340
  35. 35

    Prolonged respiratory failure responds to conventional therapy in isolated homocysteine remethylation defects.

    Whitehouse A, Rehsi P, Hartley L, et al.

    JIMD reports 2023; (64(4)):274-281 doi:10.1002/jmd2.12375.

    PMID: 37404677
  36. 36

    Evaluation of the clinical, biochemical, and genetic presentation of neonatal and adult-onset 5,10-methylene tetrahydrofolate reductase (MTHFR) deficiency in patients from Pakistan.

    Ahmed S, Akbar F, DeBerardinis RJ, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2023; (36(8)):761-771 doi:10.1515/jpem-2023-0083.

    PMID: 37440674
  37. 37

    [Analysis of 9 patients with adolescence-onset methylenetetrahydrofolate reductase deficiency].

    Zhang HT, Ma X, Jin Y, et al.

    Zhonghua er ke za zhi = Chinese journal of pediatrics 2024; (62(4)):357-362 doi:10.3760/cma.j.cn112140-20230919-00200.

    PMID: 38527507
  38. 38

    Outcomes after newborn screening for propionic and methylmalonic acidemia and homocystinurias.

    Reischl-Hajiabadi AT, Schnabel E, Gleich F, et al.

    Journal of inherited metabolic disease 2024; (47(4)):674-689 doi:10.1002/jimd.12731.

    PMID: 38563533
  39. 39

    Right iliac deep vein thrombosis and pulmonary embolism associated with recreational nitrous oxide: a case report.

    Bizouard T, Caplette C, Duval D, et al.

    International journal of emergency medicine 2024; (17(1)):169 doi:10.1186/s12245-024-00689-z.

    PMID: 39497058
  40. 40

    RNA sequencing combined with whole-exome sequencing revealed familial homocystinemia due to MTHFR deficiency and its complex splicing events.

    Li W, Ma X, Sun Y, et al.

    Gene 2025; (936()):149101 doi:10.1016/j.gene.2024.149101.

    PMID: 39571660
  41. 41

    First episode of catatonia followed by a psychotic episode related to chronic nitrous oxide use: A case report.

    Taillefer de Laportalière T, Redon M, Roussin A, et al.

    Drug and alcohol review 2025; (44(3)):908-912 doi:10.1111/dar.14012.

    PMID: 39901315
  42. 42

    Expanding the Phenotypic Spectrum of Methylenetetrahydrofolate Reductase (MTHFR) Deficiency in Childhood: A Case Series.

    Loftus E, Elbishari Z, Fitzsimons P, et al.

    Clinical case reports 2025; (13(7)):e9660 doi:10.1002/ccr3.9660.

    PMID: 40575625
  43. 43

    Development of a novel liquid chromatography-tandem mass spectrometry based enzymatic assay of 5,10-methylenetetrahydrofolate reductase.

    Sunoki K, Watanabe M, Aoki S, et al.

    Scientific reports 2025; (15(1)):22674.

    PMID: 40596302
  44. 44

    First Revision of the Guidelines for the Diagnosis and Management of Remethylation Disorders.

    Olivieri G, Bordugo A, Burnyte B, et al.

    Journal of inherited metabolic disease 2026; (49(4)):e70177 doi:10.1002/jimd.70177.

    PMID: 42231716
  45. 45

    A Pediatric Case of Homocystinuria Due to MTHFR Deficiency with Early Clinical Features Resembling Leigh Encephalopathy.

    Itabashi T, Abe J, Nakajima M, et al.

    Children (Basel, Switzerland) 2026; (13(10)) doi:10.3390/children13101332.

    PMID: 42940651